CompuGroup Medical SE KGaA Valuation
Is COP1 N undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of COP1 N when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: COP1 N (MX$1396.8) is trading above our estimate of fair value (MX$1158.53)
Significantly Below Fair Value: COP1 N is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for COP1 N?
Key metric: As COP1 N is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is COP1 N's PE Ratio? | |
|---|---|
| PE Ratio | 34.8x |
| Earnings | €69.58m |
| Market Cap | €2.42b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.5x |
| Enterprise Value/EBITDA | 19.2x |
| PEG Ratio | 1.7x |
Price to Earnings Ratio vs Peers
How does COP1 N's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 69.7x | ||
300253 Winning Health Technology Group | 45.5x | 34.9% | CN¥16.4b |
4483 JMDC | 66.4x | 24.9% | JP¥274.5b |
SECT B Sectra | 122.7x | 21.2% | SEK 54.9b |
NXU Nexus | 44.2x | 17.1% | €1.2b |
COP1 N CompuGroup Medical SE KGaA | 34.8x | 23.0% | Mex$2.4b |
Price-To-Earnings vs Peers: COP1 N is good value based on its Price-To-Earnings Ratio (34.8x) compared to the peer average (143.3x).
Price to Earnings Ratio vs Industry
How does COP1 N's PE Ratio compare vs other companies in the Global Healthcare Services Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: COP1 N is expensive based on its Price-To-Earnings Ratio (34.8x) compared to the Global Healthcare Services industry average (34.4x).
Price to Earnings Ratio vs Fair Ratio
What is COP1 N's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 34.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate COP1 N's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.